Litcius/Paper detail

Rubia cordifolia L. ameliorates DSS-induced ulcerative colitis in mice through dual inhibition of NLRP3 inflammasome and IL-6/JAK2/STAT3 pathways

Wei Qin, Han Luo, Yang Liu, Di Hu, Suping Jiang, Daiyin Peng, Jiang‐Miao Hu, Shou‐Jin Liu

2022Heliyon32 citationsDOIOpen Access PDF

Abstract

​L. (RCEE) to treat Ulcerative colitis (UC) effectively is still unclear. In this study, DSS successfully induced UC mice and then intervene using different polar parts of RCEE. The results indicated that RCEE-treatment inhibited colonic combination NLRP3 inflammasome formation and IL-6/JAK2/STAT3 activation in vivo, significantly ameliorating the clinical symptoms, including alleviating colonic mucosal damage and infiltration of macrophages, suppressing the release of inflammatory cytokines, and reducing mortality. Taken together, this study suggests that dual inhibition of NLRP3 inflammasome and IL-6/JAK2/STAT3 pathways activation using RCEE may be a promising therapeutic strategy for preventing the progression of UC.

Topics & Concepts

InflammasomeUlcerative colitisSTAT3MedicineIn vivoPharmacologyColitisInflammationTraditional medicineChemistryImmunologySignal transductionBiologyInternal medicineBiochemistryDiseaseBiotechnologyPharmacological Effects of Natural CompoundsInflammasome and immune disordersInflammation biomarkers and pathways
Rubia cordifolia L. ameliorates DSS-induced ulcerative colitis in mice through dual inhibition of NLRP3 inflammasome and IL-6/JAK2/STAT3 pathways | Litcius